The 6th Virtual Clinical Trial Conference, a trusted conference on decentralized trials, invites professionals, clinicians, and vendors of the pharma, medical device, and biotech fields. The event is hosted by Dynamic Global Events (“DGE”), a Life Science Leader in organizing B2B Events. The global event company focuses on meeting the dynamic informational and networking needs of the Pharmaceutical, Biotechnology, Healthcare, Medical Devices, and allied industries.
As clinical trials are switching to more decentralized and hybrid models, more information on the successful implementation and the future scope of clinical trials must be discussed and analyzed over a collaborative platform. At the 6th Virtual Clinical Trials Conference, hear and learn from discussions about actual clinical trial case studies that are implementing DCT’s. Attendees will deep dive into the intricacies involved in SOP’s and discuss the future of these trials with leading industry leaders.
Dignitaries and eminent personalities of the pharma and healthcare industries will reside as speakers to discuss the exclusive insights on the successful implementation of decentralized trials and what challenges can be overcome in data compliance, regulatory compliance, and patient retention. These pharma industry professionals and experts will offer all-new insights on constructing and measuring endpoints, executing effective patient recruitment strategies, and applying new technologies along with novel strategies and viewpoints.
The 2-day event platform can be leveraged by professionals in clinical operations, research, digital health, scientific affairs, technical solutions, strategy, innovation, quality, and planning officers, as well as medical managers, directors, auditors, and medical advisors.
The agenda of the conference focuses is:
- Engaging patients the right way by ensuring a reduction in patient burden thereby improves retention and reduces the project cost
- Allow for speedy data accumulation and quick timelines by doing away with on-site visits
- Reduce workload for clinical trial sites for better time and cost efficiencies by monitoring regulatory and process improvements
- Incorporate efficient processes into the trial design to overcome the laxity in the trial process
- Improve safety monitoring, safety producers, and follow up outcomes
In addition, attendees can gain immense knowledge about the various facets of decentralized clinical trials. Explore the most innovative ways to conduct clinical trials, measure their success and understand the next-generation clinical trial data management. This conference is taking place at The Inn at Penn, a Hilton Hotel, Philadelphia, US on May 18-19, 2022 In Person.
To learn more, please visit https://dgevents.com/event/virtual-clinical-trials/.
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]